triple hormone receptor agonist retatrutide for obesity is a triple-agonist drug targeting GLP-1, GIP, and glucagon receptors to suppress appetite and boost thermogenesis. Phase 2 trials reported 24.2% average weight loss and over 80% liver fat reduction, reversing Retatrutide for weight loss: Study

In contrast, Th17 cells are distinguished by the secretion of pro-inflammatory cytokines, such as IL-17 and IL-21, which are of great significance in initiating inflammatory responses and combating specific pathogens [144]

The new insights of DPP-4 inhibitors: their potential immune modulatory function in autoimmune diabetes

Dawed AY, Zhou K, van Leeuwen N, Mahajan A, Robertson N, Koivula R, Elders PJM, Rauh SP, Jones AG, Holl RW, Stingl JC, Franks PW, McCarthy MI, t Hart LM, Pearson ER

Their complementary mechanisms one acting primarily through growth factor upregulation and GI-cytoprotection, the other through actin polymerization and systemic cell migration make them uniquely interesting both individually and as a combined research subject